3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Pancreatic Cancer Non-resectable
1
Marijuana Abuse
1
Carcinoma, Hepatocellular
1
Interventions
Oxaliplatin
1004
Fluorouracil
800
Capecitabine
765
Gemcitabine
651
Leucovorin
559
Irinotecan
537
Bevacizumab
513
Radiotherapy
460
Cisplatin
441
Drug Therapy
298
Cetuximab
280
Surgical Procedures, Operative
229
Paclitaxel
228
S 1 (combination)
218
pembrolizumab
206
Docetaxel
199
130-nm albumin-bound paclitaxel
196
Nivolumab
193
sintilimab
191
Radiosurgery
190
lenvatinib
181
Folfox protocol
179
Sorafenib
178
Albumin-Bound Paclitaxel
173
apatinib
170
tislelizumab
161
camrelizumab
160
Neoadjuvant Therapy
158
Blood Specimen Collection
154
durvalumab
148
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Medical Marijuana
×
Gastrointestinal
×
Clear all
NCT06605430
2025-07-29
CanPan-C
HealthPartners Institute
Phase 2
Recruiting
64 enrolled
NCT06518434
2024-07-24
CanHep
University Medical Center Groningen
Phase 2
Recruiting
20 enrolled